BlackRock Institutional Trust’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $745M | Buy |
6,089,611
+118,510
| +2% | +$14.5M | 0.11% | 188 |
|
|
2016
Q3 | $732M | Buy |
5,971,101
+284,747
| +5% | +$34.9M | 0.11% | 178 |
|
|
2016
Q2 | $664M | Buy |
5,686,354
+84,485
| +2% | +$9.86M | 0.11% | 189 |
|
|
2016
Q1 | $780M | Buy |
5,601,869
+15,733
| +0.3% | +$2.19M | 0.13% | 158 |
|
|
2015
Q4 | $1.07B | Sell |
5,586,136
-1,015
| -0% | -$194K | 0.18% | 112 |
|
|
2015
Q3 | $874M | Sell |
5,587,151
-59,671
| -1% | -$9.33M | 0.15% | 131 |
|
|
2015
Q2 | $1.02B | Buy |
5,646,822
+351,002
| +7% | +$63.5M | 0.16% | 117 |
|
|
2015
Q1 | $918M | Buy |
5,295,820
+186,951
| +4% | +$32.4M | 0.14% | 137 |
|
|
2014
Q4 | $945M | Buy |
5,108,869
+37,005
| +0.7% | +$6.85M | 0.15% | 130 |
|
|
2014
Q3 | $841M | Sell |
5,071,864
-11,552
| -0.2% | -$1.92M | 0.14% | 145 |
|
|
2014
Q2 | $794M | Sell |
5,083,416
-167,216
| -3% | -$26.1M | 0.13% | 158 |
|
|
2014
Q1 | $799M | Buy |
5,250,632
+221,938
| +4% | +$33.8M | 0.14% | 146 |
|
|
2013
Q4 | $668M | Sell |
5,028,694
-89,198
| -2% | -$11.9M | 0.12% | 170 |
|
|
2013
Q3 | $594M | Sell |
5,117,892
-47,941
| -0.9% | -$5.57M | 0.11% | 179 |
|
|
2013
Q2 | $476M | Buy |
+5,165,833
| New | +$476M | 0.1% | 210 |
|